Lakefront Biotherapeutics (GLPGF) Shares Outstanding (2013 - 2026)

Lakefront Biotherapeutics (GLPGF) has reported Shares Outstanding (Entity) for 13 consecutive years, with $65.9 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.0% year-over-year to $65.9 million in Q4 2025; TTM through Dec 2025 was $65.9 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $65.9 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) was $65.9 million for Q4 2025 at Lakefront Biotherapeutics, roughly flat from $65.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $65.9 million in Q4 2023 and troughed at $65.6 million in Q4 2021.
• A 5-year average of $65.8 million and a median of $65.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) rose 0.43% in 2022 and changed 0.0% in 2024, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $65.6 million in 2021, then grew by 0.43% to $65.8 million in 2022, then gained by 0.09% to $65.9 million in 2023, then changed by 0.0% to $65.9 million in 2024, then changed by 0.0% to $65.9 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $65.9 million (Q4 2025), $65.9 million (Q4 2024), and $65.9 million (Q4 2023), per Business Quant data.